Delay in seeking medical advice and late presentation of female breast cancer patients in most of the world. Could we make changes? The experience of 23 years in port said, Egypt
Delay in seeking medical advice and late presentation of female breast cancer patients in most of the world. Could we make changes? The experience of 23 years in port said, Egypt
复制标题
DOI：
10.1159/000113936
复制
发表时间：
2008-02-01
期刊：
影响因子：
2.1
通讯作者：
Badran, Atef
中科院分区：
文献类型：
--
作者：
Ezawawy, Ahmed M.;Elbahaie, Aaadeen M.;Badran, Atef
背景：在低收入和中等收入国家，延迟就诊、延迟就诊以及为所有患者提供乳腺癌治疗是重大挑战。材料和方法：对 2004 年至 2006 年埃及塞得港女性乳腺癌患者就医延迟和病理肿瘤大小进行了研究，并与 Elzawawy 自 1987 年以来发表的先前研究进行了比较。我们报告了从 1984 年到 2007 年 6 月底乳腺癌治疗可用性的进展。结果：晚期病例有所下降。 1987年、1989年、1999年和2007年，从出现症状到就诊的平均时间分别为18个月、8个月、3个月和1个月。1984年以来，各条综合管理设施已建成并联网，并向全体公民免费开放。结论：乳腺癌问题具有一定的复杂性。造成迟发病例的原因并非单一。然而，我们报告说，癌症管理设施的可用性可能会导致早期就诊。如果患者无法负担可用的治疗费用，早期检测计划将令患者和卫生当局都感到沮丧。
Background: In the low and middle income countries delays in seeking consultation, late presentation, and the availability of breast cancer management for all patients, represent major challenges. Materials and Methods: The delay in seeking medical advice and the pathological tumor size of females breast cancer patients in the years 2004-2006 in Port Said, Egypt were studied and compared with previous studies by Elzawawy published since 1987. We report the progress of availability of breast cancer management from 1984 until the end of June 2007. Results: There was a decline in advanced cases. Mean time from a symptom to seeking advice was 18, 8, 3, and 1 month respectively in 1987, 1989, 1999, and 2007. Since 1984, facilities for all lines of comprehensive management have been established, interconnected, and been made accessible for all citizens, free of charge. Conclusion: Breast cancer problems are characterized by a certain multi-complexity. There is no one single cause for late cases. However, we report that the availability of cancer management facilities could lead to earlier presentation. Early detection programs would be frustrating for both patients and health authorities if patients were unable to afford accessible treatment.